Diagnosis and Management of Primary Amenorrhea and Female Delayed Puberty
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Non Hormonal Management of Menstrual Cylce Irregularities
Journal of Gynecology and Women’s Health ISSN 2474-7602 Review Article J Gynecol Women’s Health Volume 11 Issue 4 - September 2018 Copyright © All rights are reserved by Arif A Faruqui DOI: 10.19080/JGWH.2018.11.555818 Non Hormonal Management of Menstrual Cylce Irregularities Arif A Faruqui* Department of Pharmacology, Clinical Pharmacologist, A 504, Rizvi Mahal, India Submission: August 16, 2018; Published: September 07, 2018 *Corresponding author: Email: Arif A Faruqui, Department of Pharmacology, A 504, Rizvi Mahal Opp. K.B. Bhabha Hospital, Waterfield road Bandra, India, Abstract of bleedingEach month patterns, the endometriumfor example, amenorrhea, becomes inflamed, menorrhagia and the or luminalpolymenorrhea; portion ovarianis shed dysfunctionduring menstruation. for example, Aberrations anovulation in menstrualand luteal physiology can lead to common gynecological conditions, such as heavy or prolonged bleeding. Menstrual dysfunction is defined in terms pathologic process or may predispose a woman to the development of chronic disease. For example, metrorrhagia predisposes to anemia, anddeficiency; the irregular painful menstrual menstruation cycles and associated premenstrual with PCOS syndrome. (see PCOS) Certain can characteristics predispose a woman of menstruation to infertility, can diabetes be a reflection and consequently, of an underlying heart disease. What is it, in this age of life-saving antibiotics, hormonal therapy, surgeries and other seemingly miraculous medical therapies that causes so many individuals to seek therapies outside of conventional medicine? Conventional medicine may be at its best when treating acute crises, but for the treatment of chronic problems it may fall short of offering either cure or healing, leading patients to seek out systems of treatment that they perceive as addressing the causes of their problem, not just the symptoms. -
Successful Uterovaginal Anastomosis in an Unusual Presentation Of
JSAFOMS Successful Uterovaginal Anastomosis in an Unusual Presentation10.5005/jp-journals-10032-1056 of Congenital Absence of Cervix CASE REPORT Successful Uterovaginal Anastomosis in an Unusual Presentation of Congenital Absence of Cervix 1Nusrat Mahmud, 2Naushaba Tarannum Mahtab, 3TA Chowdhury, 4Anjan Kumar Deb ABSTRACT Source of support: Nil Cervical agenesis or dysgenesis (fragmentation, fibrous cord Conflict of interest: None and obstruction) is an extremely rare congenital anomaly. Conser vative surgical approach to these patients involves uterovaginal anastomosis, cervical canalization and cervical INTRODUCTION reconstruction. In failed conservative surgery, total hysterec- Primary amenorrhea is defined as absence of menstrua- tomy is the treatment of choice. We report what we believe to be the first successful end-to-end uterovaginal anastomosis of tion by the age of 14 years in the absence of secondary an unusual case of congenital cervical agenesis. A 25-year- sex characteristics or the absence of periods by the age of old female presented complaining of primary amenorrhea 16 years regardless of appearance of secondary sex and primary subfertility for the same duration. At laparoscopy, complete separation between the cervix and the body of the charac ters. In our last study, a series of total 108 cases uterus was found and hanging from surrounding supports. of primary amenorrhea were reviewed. It was found Both ovaries and fallopian tubes were anatomically positioned. that 69.4% were due Müllerian dysgenesis, 19.4% due to There was another muscular tissue of 2 cm in diameter at the gonadal dysgenesis, 2.7% male pseudohermaphroditism pouch of Douglas which was attached with lateral pelvic wall 13 by transverse cervical ligament. -
Background Briefing Document from the Consortium of Sponsors for The
BRIEFING BOOK FOR Pediatric Advisory Committee (PAC) Prepared by Alan Rogol, M.D., Ph.D. Prepared for Consortium of Sponsors Meeting Date: April 8th, 2019 TABLE OF CONTENTS LIST OF FIGURES ................................................... ERROR! BOOKMARK NOT DEFINED. LIST OF TABLES ...........................................................................................................................4 1. INTRODUCTION AND BACKGROUND FOR THE MEETING .............................6 1.1. INDICATION AND USAGE .......................................................................................6 2. SPONSOR CONSORTIUM PARTICIPANTS ............................................................6 2.1. TIMELINE FOR SPONSOR ENGAGEMENT FOR PEDIATRIC ADVISORY COMMITTEE (PAC): ............................................................................6 3. BACKGROUND AND RATIONALE .........................................................................7 3.1. INTRODUCTION ........................................................................................................7 3.2. PHYSICAL CHANGES OF PUBERTY ......................................................................7 3.2.1. Boys ..............................................................................................................................7 3.2.2. Growth and Pubertal Development ..............................................................................8 3.3. AGE AT ONSET OF PUBERTY.................................................................................9 3.4. -
The Prevalence of and Attitudes Toward Oligomenorrhea and Amenorrhea in Division I Female Athletes
POPULATION-SPECIFIC CONCERNS The Prevalence of and Attitudes Toward Oligomenorrhea and Amenorrhea in Division I Female Athletes Karen Myrick, DNP, APRN, FNP-BC, Richard Feinn, PhD, and Meaghan Harkins, MS, BSN, RN • Quinnipiac University Research has demonstrated that amenor- hormone and follicle-stimulating hormone rhea and oligomenorrhea may be common shut down stimulation to the ovary, ceasing occurrences among female athletes.1 Due production of estradiol.2 to normalization of menstrual dysfunction The effect of oral contraceptives on the within the sport environment, amenorrhea menstrual cycle include ovulation inhibi- and oligomenorrhea tion, changes in cervical mucus, thinning may be underreported. of the uterine endometrium, and motility Key PointsPoints There are many underly- and secretion in the fallopian tubes, which Lean sport athletes are more likely to per- ing causes of menstrual decrease the likelihood of conception and 3 ceive missed menstrual cycles as normal. dysfunction. However, implantation. Oral contraceptives contain a a similar hypothalamic combination of estrogen and progesterone, Menstrual dysfunction is one prong of the amenorrhea profile is or progesterone only; thus, oral contracep- female athlete triad. frequently seen in ath- tives do not stop the production of estrogen. letes, and hypothalamic Menstrual dysfunction is one prong of the Menstrual dysfunction is often associated dysfunction is com- female athlete triad (triad). The triad is a with musculoskeletal and endothelial monly the root of ath- syndrome of linking low energy availability compromise. lete’s menstrual abnor- (EA) with or without disordered eating, men- malities.2 The common strual disturbances, and low bone mineral Education and awareness of the accultur- hormone pattern for density, across a continuum. -
Cervical and Vaginal Agenesis: a Novel Anomaly
Cervical and Vaginal Agenesis: A Novel Anomaly Case Report Cervical and Vaginal Agenesis: A Novel Anomaly Irum Sohail1, Maria Habib 2 1Professor Obs/Gynae, 2Postgraduate Trainee, Wah Medical College, Wah Cantt Address of Correspondence: Dr. Maria Habib, Postgraduate Trainee, Wah Medical College, Wah Cantt Email: [email protected] Abstract Background: Cervical agenesis with vaginal agenesis is an extremely rare congenital anomaly. This mullerian anomaly occurs in 1 in 80,000-100,000 births. It is classified as type IB in the American Fertility Society Classification of mullerian anomalies. Case report: We report a case presented to POF Hospital, Wah cantt with primary amenorrhea and cyclic lower abdominal pain. She was diagnosed to have cervical agenesis associated with completely absent vagina. Conservative surgical approach to these patients involve uterovaginal anastomosis and cervical reconstruction. Creation of neovagina is necessary in these cases. Due to high failure rate and potential for complications, total hysterectomy with vaginoplasty is the treatment of choice by many authors. Conclusion: A thorough investigation of the patients with primary amenorrhea is necessary and total hysterectomy with vaginoplasty is feasible and should be considered as a first-line treatment option in cases of cervical and vaginal agenesis. Key words: Primary amenorrhea, Cervical agenesis, Vaginal agenesis, Hysterectomy. Introduction The female reproductive organs develop from the Society of Human Reproduction and Embryology fusion of the bilateral paramesonephric (Müllerian) (ESHRE)/European Society for Gynaecological ducts to form the uterus, cervix, and upper two- Endoscopy (ESGE) classification system of female thirds of the vagina.1 The lower third of the vagina genital anomalies is designed for clinical orientation develops from the sinovaginal bulbs of the and it is based on the anatomy of the female urogenital sinus.2 Mullerian duct anomalies (MDAs) genital tract. -
Genetic Syndromes and Genes Involved
ndrom Sy es tic & e G n e e n G e f Connell et al., J Genet Syndr Gene Ther 2013, 4:2 T o Journal of Genetic Syndromes h l e a r n a DOI: 10.4172/2157-7412.1000127 r p u y o J & Gene Therapy ISSN: 2157-7412 Review Article Open Access Genetic Syndromes and Genes Involved in the Development of the Female Reproductive Tract: A Possible Role for Gene Therapy Connell MT1, Owen CM2 and Segars JH3* 1Department of Obstetrics and Gynecology, Truman Medical Center, Kansas City, Missouri 2Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 3Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA Abstract Müllerian and vaginal anomalies are congenital malformations of the female reproductive tract resulting from alterations in the normal developmental pathway of the uterus, cervix, fallopian tubes, and vagina. The most common of the Müllerian anomalies affect the uterus and may adversely impact reproductive outcomes highlighting the importance of gaining understanding of the genetic mechanisms that govern normal and abnormal development of the female reproductive tract. Modern molecular genetics with study of knock out animal models as well as several genetic syndromes featuring abnormalities of the female reproductive tract have identified candidate genes significant to this developmental pathway. Further emphasizing the importance of understanding female reproductive tract development, recent evidence has demonstrated expression of embryologically significant genes in the endometrium of adult mice and humans. This recent work suggests that these genes not only play a role in the proper structural development of the female reproductive tract but also may persist in adults to regulate proper function of the endometrium of the uterus. -
Uterine Conserving Surgery in a Case of Cervicovaginal Agenesis with Cloacal Malformation
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Mishra V et al. Int J Reprod Contracept Obstet Gynecol. 2017 Mar;6(3):1144-1148 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20170604 Case Report Uterine conserving surgery in a case of cervicovaginal agenesis with cloacal malformation Vineet Mishra1*, Suwa Ram Saini2, Priyankur Roy1, Rohina Aggarwal1, Ruchika Verneker1, Shaheen Hokabaj1 1Department of Obstetrics and Gynecology, IKDRC, Ahmedabad, Gujarat, India 2Department of Obstetrics and Gynecology, S. P. Medical College, Bikaner, Rajasthan, India Received: 30 December 2016 Accepted: 02 February 2017 *Correspondence: Dr. Vineet Mishra, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Cervico-vaginal agenesis (MRKHS) with normally formed uterus along with cloacal malformation is a very rare mullerian anomaly. We report a case, of a 13-year-old girl who was admitted at our tertiary care center with complaints of primary amenorrhea and cyclical lower abdominal pain for 3 months. Clinical examination and radiological investigations revealed complete cervico-vaginal agenesis with normal uterus with hematometra with horse shoe kidney. Vaginoplasty was done by McIndoe’s method with uterovaginal anastomosis and neocervix formation. Malecot’s catheter was inserted in uterine cavity. Vaginal mould was kept in the neovagina. Mould was removed after 10 days under anaesthesia and repeat hysteroscopy with insertion of a small piece of malecot’s catheter was performed under hysteroscopic guidance into the uterine cavity through neocervix and lower end fixed to the vagina. -
AMENORRHOEA Amenorrhoea Is the Absence of Menses in a Woman of Reproductive Age
AMENORRHOEA Amenorrhoea is the absence of menses in a woman of reproductive age. It can be primary or secondary. Secondary amenorrhoea is absence of periods for at least 3 months if the patient has previously had regular periods, and 6 months if she has previously had oligomenorrhoea. In contrast, oligomenorrhoea describes infrequent periods, with bleeds less than every 6 weeks but at least one bleed in 6 months. Aetiology of amenorrhea in adolescents (from Golden and Carlson) Oestrogen- Oestrogen- Type deficient replete Hypothalamic Eating disorders Immaturity of the HPO axis Exercise-induced amenorrhea Medication-induced amenorrhea Chronic illness Stress-induced amenorrhea Kallmann syndrome Pituitary Hyperprolactinemia Prolactinoma Craniopharyngioma Isolated gonadotropin deficiency Thyroid Hypothyroidism Hyperthyroidism Adrenal Congenital adrenal hyperplasia Cushing syndrome Ovarian Polycystic ovary syndrome Gonadal dysgenesis (Turner syndrome) Premature ovarian failure Ovarian tumour Chemotherapy, irradiation Uterine Pregnancy Androgen insensitivity Uterine adhesions (Asherman syndrome) Mullerian agenesis Cervical agenesis Vaginal Imperforate hymen Transverse vaginal septum Vaginal agenesis The recommendations for those who should be evaluated have recently been changed to those shown below. (adapted from Diaz et al) Indications for evaluation of an adolescent with primary amenorrhea 1. An adolescent who has not had menarche by age 15-16 years 2. An adolescent who has not had menarche and more than three years have elapsed since thelarche 3. An adolescent who has not had a menarche by age 13-14 years and no secondary sexual development 4. An adolescent who has not had menarche by age 14 years and: (i) there is a suspicion of an eating disorder or excessive exercise, or (ii) there are signs of hirsutism, or (iii) there is suspicion of genital outflow obstruction Pregnancy must always be excluded. -
Hypogonadism in Adolescence 173:1 R15–R24 Review
A A Dwyer and others Hypogonadism in adolescence 173:1 R15–R24 Review TRANSITION IN ENDOCRINOLOGY Hypogonadism in adolescence Andrew A Dwyer1,2, Franziska Phan-Hug1,3, Michael Hauschild1,3, Eglantine Elowe-Gruau1,3 and Nelly Pitteloud1,2,3,4 1Center for Endocrinology and Metabolism in Young Adults (CEMjA), 2Endocrinology, Diabetes and Metabolism Correspondence Service and 3Division of Pediatric Endocrinology Diabetology and Obesity, Department of Pediatric Medicine and should be addressed Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 46, 1011 Lausanne, Switzerland and to N Pitteloud 4Department of Physiology, Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 7, Email 1005 Lausanne, Switzerland [email protected] Abstract Puberty is a remarkable developmental process with the activation of the hypothalamic–pituitary–gonadal axis culminating in reproductive capacity. It is accompanied by cognitive, psychological, emotional, and sociocultural changes. There is wide variation in the timing of pubertal onset, and this process is affected by genetic and environmental influences. Disrupted puberty (delayed or absent) leading to hypogonadism may be caused by congenital or acquired etiologies and can have significant impact on both physical and psychosocial well-being. While adolescence is a time of growing autonomy and independence, it is also a time of vulnerability and thus, the impact of hypogonadism can have lasting effects. This review highlights the various forms of hypogonadism in adolescence and the clinical challenges in differentiating normal variants of puberty from pathological states. In addition, hormonal treatment, concerns regarding fertility, emotional support, and effective transition to adult care are discussed. European Journal of Endocrinology (2015) 173, R15–R24 European Journal of Endocrinology Introduction Adolescence is generally defined as the transitional phase (FSH)) (1, 2). -
Current Evaluation of Amenorrhea
Current evaluation of amenorrhea The Practice Committee of the American Society for Reproductive Medicine Birmingham, Alabama Amenorrhea is the absence or abnormal cessation of the menses. Primary and secondary amenorrhea describe the occurrence of amenorrhea before and after menarche, respectively. (Fertil Steril 2006;86(Suppl 4):S148–55. © 2006 by American Society for Reproductive Medicine.) Amenorrhea is the absence or abnormal cessation of the menses complaint. The sexual ambiguity or virilization should be (1). Primary and secondary amenorrhea describe the occurrence evaluated as separate disorders, mindful that amenorrhea is of amenorrhea before and after menarche, respectively. The an important component of their presentation (9). majority of the causes of primary and secondary amenorrhea are similar. Timing of the evaluation of primary amenorrhea EVALUATION OF THE PATIENT recognizes the trend to earlier age at menarche and is therefore History, physical examination, and estimation of follicle indicated when there has been a failure to menstruate by age 15 stimulating hormone (FSH), thyroid stimulating hormone in the presence of normal secondary sexual development (two (TSH), and prolactin will identify the most common causes standard deviations above the mean of 13 years), or within five of amenorrhea (Fig. 1). The presence of breast development years after breast development if that occurs before age 10 (2). means there has been previous estrogen action. Excessive Failure to initiate breast development by age 13 (two standard testosterone secretion is suggested most often by hirsutism deviations above the mean of 10 years) also requires investiga- and rarely by increased muscle mass or other signs of viril- tion (2). -
Blueprint Genetics Craniosynostosis Panel
Craniosynostosis Panel Test code: MA2901 Is a 38 gene panel that includes assessment of non-coding variants. Is ideal for patients with craniosynostosis. About Craniosynostosis Craniosynostosis is defined as the premature fusion of one or more cranial sutures leading to secondary distortion of skull shape. It may result from a primary defect of ossification (primary craniosynostosis) or, more commonly, from a failure of brain growth (secondary craniosynostosis). Premature closure of the sutures (fibrous joints) causes the pressure inside of the head to increase and the skull or facial bones to change from a normal, symmetrical appearance resulting in skull deformities with a variable presentation. Craniosynostosis may occur in an isolated setting or as part of a syndrome with a variety of inheritance patterns and reccurrence risks. Craniosynostosis occurs in 1/2,200 live births. Availability 4 weeks Gene Set Description Genes in the Craniosynostosis Panel and their clinical significance Gene Associated phenotypes Inheritance ClinVar HGMD ALPL Odontohypophosphatasia, Hypophosphatasia perinatal lethal, AD/AR 78 291 infantile, juvenile and adult forms ALX3 Frontonasal dysplasia type 1 AR 8 8 ALX4 Frontonasal dysplasia type 2, Parietal foramina AD/AR 15 24 BMP4 Microphthalmia, syndromic, Orofacial cleft AD 8 39 CDC45 Meier-Gorlin syndrome 7 AR 10 19 EDNRB Hirschsprung disease, ABCD syndrome, Waardenburg syndrome AD/AR 12 66 EFNB1 Craniofrontonasal dysplasia XL 28 116 ERF Craniosynostosis 4 AD 17 16 ESCO2 SC phocomelia syndrome, Roberts syndrome -
MECHANISMS in ENDOCRINOLOGY: Novel Genetic Causes of Short Stature
J M Wit and others Genetics of short stature 174:4 R145–R173 Review MECHANISMS IN ENDOCRINOLOGY Novel genetic causes of short stature 1 1 2 2 Jan M Wit , Wilma Oostdijk , Monique Losekoot , Hermine A van Duyvenvoorde , Correspondence Claudia A L Ruivenkamp2 and Sarina G Kant2 should be addressed to J M Wit Departments of 1Paediatrics and 2Clinical Genetics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Email The Netherlands [email protected] Abstract The fast technological development, particularly single nucleotide polymorphism array, array-comparative genomic hybridization, and whole exome sequencing, has led to the discovery of many novel genetic causes of growth failure. In this review we discuss a selection of these, according to a diagnostic classification centred on the epiphyseal growth plate. We successively discuss disorders in hormone signalling, paracrine factors, matrix molecules, intracellular pathways, and fundamental cellular processes, followed by chromosomal aberrations including copy number variants (CNVs) and imprinting disorders associated with short stature. Many novel causes of GH deficiency (GHD) as part of combined pituitary hormone deficiency have been uncovered. The most frequent genetic causes of isolated GHD are GH1 and GHRHR defects, but several novel causes have recently been found, such as GHSR, RNPC3, and IFT172 mutations. Besides well-defined causes of GH insensitivity (GHR, STAT5B, IGFALS, IGF1 defects), disorders of NFkB signalling, STAT3 and IGF2 have recently been discovered. Heterozygous IGF1R defects are a relatively frequent cause of prenatal and postnatal growth retardation. TRHA mutations cause a syndromic form of short stature with elevated T3/T4 ratio. Disorders of signalling of various paracrine factors (FGFs, BMPs, WNTs, PTHrP/IHH, and CNP/NPR2) or genetic defects affecting cartilage extracellular matrix usually cause disproportionate short stature.